Greetings and happy spring! I hope you will agree that spring brings the promise of exciting new growth after the reflection and focused work of the winter months.
In the spirit of new beginnings, I am delighted to announce the appointment of Dr. Hazel D. Dean as Deputy Director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). Dr. Dean brings a wealth of knowledge, public health science, and leadership experience to the National Center.
I am also pleased to announce the availability of NCHHSTP’s first
Annual Business Report Fiscal Year 2007. The report and its accomplishments rely on the collaboration of our partners, other professionals working in the field, and our staff. Thank you for your commitment and continued support.
NCHHSTP Annual Business Report
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) is releasing its Annual Business Report for Fiscal Year 2007. The report provides Centers for Disease Control and Prevention (CDC) stakeholders, policymakers, and the general public detailed information regarding programs at NCHHSTP.
Fiscal Year 2007 provided new beginnings for NCHHSTP. The Center was formally approved as a new organizational unit, with the addition of viral hepatitis prevention to our mission. During this time, the Office of Management and Budget rated NCHHSTP as an effective program.
Accomplishments this fiscal year included implementing new recommendations for HIV testing in the United States; active support for increasing chlamydia screening of young women in private health care facilities; releasing new prevention guidelines for viral hepatitis; supporting the successful implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR); and achieving further reductions in tuberculosis (TB) cases. In addition, the report highlights how our investments and resources are contributing to CDC’s Health Protection Goals, focusing on healthy people, healthy places, global health, and preparedness.
TB Vaccines for the
Asian and Pacific
Check out our “From the Director” Web page to find our Dear Colleague Letters and more.
In March, at the 2008 National STD Prevention Conference, one study received considerable media attention. This study found that 1 in 4 (26 percent) of young women between the ages of 14 and 19 in the United States, or 3.2 million teenage girls, is infected with at least one of the most common sexually transmitted diseases (STDs): human papillomavirus (HPV), chlamydia, herpes, or trichomoniasis. The two most common STDs were HPV (18 percent) and chlamydia (4 percent). The findings underscore the importance of assuring that young women receive annual chlamydia screening and vaccination for HPV as part of a comprehensive approach to sexual health and STD prevention.
These findings helped increase national awareness about the threat STDs pose to sexual health. Public health professionals and partners can use this attention of the issue to stimulate discussions about what more can be done for our young people.